TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26607829

Group type: EXPERIMENTAL
Intervention: 25-G needle
Number of subjects: 144

Group type: COMPARATOR
Intervention: 22-G needle
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Crossover (both groups)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 25-G needle after crossover
Number of subjects: 144

Group type: COMPARATOR
Intervention: 22-G needle after crossover
Number of subjects: 144
Study: 24899137

Group type: EXPERIMENTAL
Intervention: Metformin 1,000 mg twice daily
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 21978861

Group type: EXPERIMENTAL
Intervention: Nasal high flow oxygen therapy
Number of subjects: 340

Group type: COMPARATOR
Intervention: Standard oxygen therapy (2-4 L/min via simple facemask or nasal cannulae)
Number of subjects: 340
Study: 20019672

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 2171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2171

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 2171
Study: 18614956

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (supervised, twice weekly for 8 weeks, consisting of three sets each of leg press, leg curl, and calf press)
Number of subjects: 16

Group type: COMPARATOR
Intervention: No-exercise control group
Number of subjects: 16
Study: 15845688

Group type: EXPERIMENTAL
Intervention: Fentanyl (1.5 microg/kg IV)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (no fentanyl)
Number of subjects: 18
Study: 15361060

Group type: EXPERIMENTAL
Intervention: Co-publishing RCTs in RCT Bank
Number of subjects: 7
Study: 10950043

Group type: EXPERIMENTAL
Intervention: Misoprostol rectal suppositories (200 microg tablets, 1 h before each radiation session)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (cocoa butter, 1 h before each radiation session)
Number of subjects: 16
Study: 8839313

Group type: EXPERIMENTAL
Intervention: Educational Treatment Program
Number of subjects: 54
Study: 1385372

Group type: EXPERIMENTAL
Intervention: Low molecular weight dextran + naftidrofuryl
Number of subjects: 80

Group type: COMPARATOR
Intervention: Low molecular weight dextran
Number of subjects: 80
Study: 3918431

Group type: EXPERIMENTAL
Intervention: 2 g of beta-galactosidase from Kluyveromyces lactis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sucrase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-galactosidase from Aspergillus niger
Number of subjects: 0
Study: 3806896

Group type: EXPERIMENTAL
Intervention: Antimicrobial therapy (one short course)
Number of subjects: 124

Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Antimicrobial therapy
Number of subjects: 124
Study: 31137030

Group type: EXPERIMENTAL
Intervention: Randomised controlled trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Innovative 'efficient' trial designs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Large multicentre trials
Number of subjects: 0
Study: 31606589

Group type: EXPERIMENTAL
Intervention: Lofexidine 2.16 mg/day
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Lofexidine 2.88 mg/day
Number of subjects: 681

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Lofexidine (all doses)
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Lofexidine (at higher concentrations)
Number of subjects: 681
Study: 28442303

Group type: EXPERIMENTAL
Intervention: High-dose ropinirole CR (18-24 mg/day)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Maintenance ropinirole CR (16 mg/day)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Comparison between high-dose and maintenance groups
Number of subjects: 81
Study: 26657066

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation to mothers during the perinatal period
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 23622849

Group type: COMPARATOR
Intervention: Medication switch alone (to another SSRI or to venlafaxine)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Medication switch plus cognitive behavioral therapy (CBT)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Remission (achieved by either treatment)
Number of subjects: 334

Group type: COMPARATOR
Intervention: SSRIs
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 334
Study: 21472495

Group type: EXPERIMENTAL
Intervention: Calendar with health messages (n=2695)
Number of subjects: 5633

Group type: COMPARATOR
Intervention: Calendar without health messages (n=2668)
Number of subjects: 5633
Study: 18077078

Group type: EXPERIMENTAL
Intervention: Repeated CO(2) exposures in a standardized rebreathing test
Number of subjects: 31
Study: 16603606

Group type: EXPERIMENTAL
Intervention: Procalcitonin guidance for antibiotic therapy
Number of subjects: 302

Group type: COMPARATOR
Intervention: Control group (usual practice)
Number of subjects: 302
Study: 12149660

Group type: EXPERIMENTAL
Intervention: rilmenidine therapy
Number of subjects: 23
Study: 9539593

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg
Number of subjects: 2061

Group type: EXPERIMENTAL
Intervention: droperidol 0.625 mg
Number of subjects: 2061

Group type: EXPERIMENTAL
Intervention: droperidol 1.25 mg
Number of subjects: 2061

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2061
Study: 7614176

Group type: EXPERIMENTAL
Intervention: 2 weeks of twice daily Peridex rinse (0.12% chlorhexidine gluconate) after surgery
Number of subjects: 371

Group type: COMPARATOR
Intervention: No treatment (group 1)
Number of subjects: 371

Group type: COMPARATOR
Intervention: One rinse presurgery (group 3)
Number of subjects: 371
Study: 2109558

Group type: EXPERIMENTAL
Intervention: Parenteral tobramycin and ticarcillin (n = 7)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (n = 5)
Number of subjects: 12
Study: 662565

Group type: EXPERIMENTAL
Intervention: High eye contact (85%)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Medium eye contact (50%)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Low eye contact (15%)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Eye-to-eye direction
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Eye-to-nose/mouth direction
Number of subjects: 48
Study: 31964398

Group type: EXPERIMENTAL
Intervention: Pharmacist-independent prescribing service (PIP) for 6 months
Number of subjects: 880

Group type: COMPARATOR
Intervention: Usual general practitioner (GP)-led care
Number of subjects: 880
Study: 30287210

Group type: EXPERIMENTAL
Intervention: Alirocumab 75 mg every 2 weeks (Q2W)
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: Alirocumab 150 mg every 2 weeks (Q2W)
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: Alirocumab (initially uptitrated)
Number of subjects: 909

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 909
Study: 26766119

Group type: EXPERIMENTAL
Intervention: Acute experimental stress (impending Trier Social Stress Task)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 40
Study: 24970570

Group type: EXPERIMENTAL
Intervention: Colostomy formation with mesh
Number of subjects: 240

Group type: COMPARATOR
Intervention: Colostomy formation without mesh (two types)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Colostomy formation (all types)
Number of subjects: 240
Study: 22284340

Group type: EXPERIMENTAL
Intervention: Antioxidant micronutrients and glutamine supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (isoenergetic amounts of maltodextrine)
Number of subjects: 20
Study: 20682881

Group type: EXPERIMENTAL
Intervention: Miltefosine, 50 mg capsule taken orally three times per day for 28 days
Number of subjects: 288

Group type: COMPARATOR
Intervention: Meglumine antimoniate, 20 mg/kg body weight per day for 20 days by intramuscular injection
Number of subjects: 288
Study: 19080711

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Operation alone group
Number of subjects: 90

Group type: COMPARATOR
Intervention: All groups (7 days after operation)
Number of subjects: 90

Group type: COMPARATOR
Intervention: All groups (1 month after operation)
Number of subjects: 90
Study: 16882108

Group type: EXPERIMENTAL
Intervention: Metformin + Pioglitazone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin + Rosiglitazone
Number of subjects: 0
Study: 12810423

Group type: EXPERIMENTAL
Intervention: Measurement feedback system
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control period (no feedback)
Number of subjects: 264
Study: 10591283

Group type: EXPERIMENTAL
Intervention: Medication management (titration followed by monthly visits)
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Intensive behavioral treatment (parent, school, and child components)
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Combined treatment (medication management + intensive behavioral treatment)
Number of subjects: 579

Group type: COMPARATOR
Intervention: Standard community care (treatments by community providers)
Number of subjects: 579
Study: 8693597

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with two courses of cisplatin (120 mg/m2 i.v. day one) plus bleomycin (20 mg/m2/day for 5 consecutive days in 24-hr i.v. perfusion) followed by definitive surgery and postoperative radiation therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Surgery plus postoperative radiation therapy (50-60 Gy)
Number of subjects: 96
Study: 1819631

Group type: EXPERIMENTAL
Intervention: 0.12% Cx
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 0.2% NaF
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 0.12% Cx plus 0.2% NaF
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 6110956

Group type: EXPERIMENTAL
Intervention: Single-donor platelet transfusions
Number of subjects: 34

Group type: COMPARATOR
Intervention: Multiple-donor platelet transfusions
Number of subjects: 34
Study: 31537219

Group type: EXPERIMENTAL
Intervention: Mild hypothermia (after 72 hours of treatment at 32-35 centigrade, increasing about 1 centigrade every 6 hours until normal temperature)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment (lowering intracranial pressure, anticoagulation, improving microcirculation, neurotrophy and anti-stress ulcer)
Number of subjects: 60
Study: 30161205

Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Atazanavir + Ritonavir (ATV/r)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Darunavir + Ritonavir (DRV/r)
Number of subjects: 96
Study: 26794168

Group type: EXPERIMENTAL
Intervention: Provider training intervention at clinics (4-hour training)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Medicaid family planning expansion programs
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Public health insurance
Number of subjects: 1500
Study: 25811824

Group type: EXPERIMENTAL
Intervention: IVR (interactive voice recognition calls)
Number of subjects: 21752

Group type: EXPERIMENTAL
Intervention: IVR+ (interactive voice recognition calls plus additional support)
Number of subjects: 21752

Group type: EXPERIMENTAL
Intervention: IVR+
Number of subjects: 21752

Group type: COMPARATOR
Intervention: UC (usual care)
Number of subjects: 21752
Study: 22339238

Group type: EXPERIMENTAL
Intervention: Structured self-monitoring of blood glucose (SMBG) intervention
Number of subjects: 375
Study: 19136164

Group type: EXPERIMENTAL
Intervention: 4 g of intravenous magnesium sulfate
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 19298023

Group type: EXPERIMENTAL
Intervention: Oxinium (OX) femoral heads
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cobalt-chrome (CC) femoral heads
Number of subjects: 100
Study: 15778240

Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg/6 weeks)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 82
Study: 12027982

Group type: COMPARATOR
Intervention: Homologous blood transfusion
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion (ANH and ICS)
Number of subjects: 145
Study: 10720121

Group type: EXPERIMENTAL
Intervention: Sham feeding in healthy volunteers
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham feeding in ACP patients
Number of subjects: 8
Study: 9028511

Group type: EXPERIMENTAL
Intervention: 1000 micrograms of inhaled beclomethasone dipropionate
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 2.5 mg of oral prednisone
Number of subjects: 8

Group type: COMPARATOR
Intervention: Inhaled placebo
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 500 micrograms of inhaled beclomethasone dipropionate
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 5 mg of oral prednisone
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 10 mg of oral prednisone
Number of subjects: 8
Study: 1900480

Group type: EXPERIMENTAL
Intervention: 10 mg/d of RU486 for 4 days from the date of ovulation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 6872419

Group type: EXPERIMENTAL
Intervention: Metkephamid 140 mg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Meperidine 100 mg
Number of subjects: 59

Group type: COMPARATOR
Intervention: Metkephamid 70 mg
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 31634646

Group type: EXPERIMENTAL
Intervention: EGFR mutation
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: History of pneumonia
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Gastroesophageal reflux disease
Number of subjects: 214
Study: 30241426

Group type: COMPARATOR
Intervention: Very Low-Calorie Ketogenic (VLCK) diet
Number of subjects: 20
Study: 27799650

Group type: EXPERIMENTAL
Intervention: mRDTs and ACTs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Presumptive diagnosis for malaria based on clinical symptoms (Control)
Number of subjects: 0
Study: 24356952

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (300,000 IU single oral bolus)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 21900625

Group type: EXPERIMENTAL
Intervention: Arthroscopic medial retinaculum plication (MRP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open vastus medialis plasty (VMP)
Number of subjects: 60
Study: 20072066

Group type: EXPERIMENTAL
Intervention: Back squat exercise (1 set of 5 repetitions at 85% 1RM) with recovery durations of 5, 10, 15, or 20 minutes
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control session (baseline measures on a 30‐second Wingate Test)
Number of subjects: 12
Study: 18025884

Group type: EXPERIMENTAL
Intervention: Alendronate plus calcium/vitamin D
Number of subjects: 82

Group type: COMPARATOR
Intervention: Calcium/vitamin D alone
Number of subjects: 82
Study: 16216756

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Verapamil (including crossover results)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Amiodarone (including crossover results)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of verapamil and amiodarone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Verapamil and/or Amiodarone (long-term follow-up)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Patients without IRAF (long-term follow-up)
Number of subjects: 20
Study: 12120714

Group type: EXPERIMENTAL
Intervention: RMGIC with horizontal increments and indirect/direct light curing (Group I)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RMGIC with diagonal increments and indirect/direct light curing (Group II)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RMGIC with diagonal increments and indirect/direct light curing using a transparent matrix (Group III)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RMGIC with diagonal increments and indirect/direct light curing with a separating liner (Group IV)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Closed sandwich restoration (Group V)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RMGIC at cervical margins
Number of subjects: 40
Study: 10426837

Group type: EXPERIMENTAL
Intervention: Metoprolol alone
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Metoprolol combined with amlodipine
Number of subjects: 29
Study: 8435244

Group type: COMPARATOR
Intervention: AAI pacing
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: AAIR pacing
Number of subjects: 30
Study: 3299130

Group type: EXPERIMENTAL
Intervention: Rotating treatment tables
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (nonrotated)
Number of subjects: 15
Study: 28635532

Group type: EXPERIMENTAL
Intervention: PHQ-15 somatic symptom severity subscale
Number of subjects: 495
Study: 27230565

Group type: EXPERIMENTAL
Intervention: Cooking with Kids - Colorado; experiential classroom-based cooking and tasting curriculum
Number of subjects: 1584

Group type: EXPERIMENTAL
Intervention: Cafeteria Connections; cafeteria-based reinforcements of classroom food experiences using behavioral economic strategies
Number of subjects: 1584

Group type: EXPERIMENTAL
Intervention: SPARK active recess; playground intervention to engage children in moderate to vigorous activity
Number of subjects: 1584

Group type: EXPERIMENTAL
Intervention: Fuel for Fun Family; multi-element supports targeting parents to reinforce school-based components at home
Number of subjects: 1584

Group type: EXPERIMENTAL
Intervention: About Eating; online interactive program for parents addressing constructs of eating competence and food resource management
Number of subjects: 1584

Group type: EXPERIMENTAL
Intervention: School-level data
Number of subjects: 1584

Group type: EXPERIMENTAL
Intervention: In-depth diet and accelerometry assessments with a subsample of parent-child dyads
Number of subjects: 1584
Study: 24828537

Group type: EXPERIMENTAL
Intervention: 0.10 mmol/kg Gd‐BOPTA
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 0.15 mmol/kg Gd‐BOPTA
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 0.20 mmol/kg Gd‐BOPTA
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Imaging at 5 min
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Imaging at 10 min with 0.10 mmol/kg Gd‐BOPTA
Number of subjects: 34
Study: 22555795

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 21029816

Group type: EXPERIMENTAL
Intervention: Transfer for primary PCI
Number of subjects: 3602

Group type: COMPARATOR
Intervention: Direct admission to PCI center
Number of subjects: 3602

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 3602

Group type: COMPARATOR
Intervention: Unfractionated heparin plus glycoprotein IIb/IIIa inhibitor
Number of subjects: 3602
Study: 18576289

Group type: EXPERIMENTAL
Intervention: 12-week supervised home-based quadriceps strengthening
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 107
Study: 16076708

Group type: EXPERIMENTAL
Intervention: Bimodal stimulation (CI + contralateral HA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: CI alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Best-aided condition preoperatively
Number of subjects: 12
Study: 11839994

Group type: EXPERIMENTAL
Intervention: Warm environment (35 degrees C, 45% relative humidity)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cool environment (18 degrees C, 65% relative humidity)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CABG group in warm environment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups in warm and cool environments
Number of subjects: 30
Study: 9880280

Group type: EXPERIMENTAL
Intervention: Hypoxaemia (defined as arterial oxygen saturation <90%)
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Clinical predictors of hypoxaemia
Number of subjects: 1072

Group type: COMPARATOR
Intervention: Presence of malaria parasitaemia
Number of subjects: 1072
Study: 8886214

Group type: EXPERIMENTAL
Intervention: Naprelan 1,000 mg once daily
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Naprosyn 500 mg BID
Number of subjects: 348

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 348
Study: 1858084

Group type: EXPERIMENTAL
Intervention: SK&F 104353‐Z2
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6306179

Group type: EXPERIMENTAL
Intervention: Dibromodulcitol (DBD) during radiotherapy, continued with DBD
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Dibromodulcitol (DBD) during radiotherapy followed by combination chemotherapy of CCNU and DBD
Number of subjects: 91

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 91
Study: 31222379

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI) for 15 minutes at 15 °C
Number of subjects: 11

Group type: COMPARATOR
Intervention: Passive recovery (Control)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI)
Number of subjects: 11
Study: 28241037

Group type: EXPERIMENTAL
Intervention: 10 mg bisacodyl plus 2 L PEG‐ELP (group B)
Number of subjects: 700

Group type: COMPARATOR
Intervention: 2 L PEG‐ELP (group A)
Number of subjects: 700

Group type: COMPARATOR
Intervention: 2 L PEG‐ELP (group C)
Number of subjects: 700
Study: 26420134

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 6000
Study: 24128821

Group type: EXPERIMENTAL
Intervention: Fentanyl pectin nasal spray (FPNS) at 100-800 μg titrated doses
Number of subjects: 401
Study: 22656865

Group type: COMPARATOR
Intervention: Conventional radiotherapy (CR) 25x2 Gy/5 weeks plus sequential boost 8x2 Gy/2 weeks (cumulative dose 66 Gy/7 weeks)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Hypofractionated Tomotherapy (TT) 15x2.8 Gy/3 weeks (cumulative dose 51 Gy/3 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional radiotherapy (CR)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Hypofractionated Tomotherapy (TT)
Number of subjects: 70
Study: 19092004

Group type: EXPERIMENTAL
Intervention: St Georg Sled UKR
Number of subjects: 102

Group type: COMPARATOR
Intervention: Kinematic modular total knee replacement (TKR)
Number of subjects: 102
Study: 17298932

Group type: EXPERIMENTAL
Intervention: Lifetime history of STI
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Treatment for an STI
Number of subjects: 464